"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
| Descriptor ID |
D015415
|
| MeSH Number(s) |
D23.101
|
| Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 7 | 9 |
| 1997 | 0 | 7 | 7 |
| 1998 | 0 | 4 | 4 |
| 1999 | 1 | 10 | 11 |
| 2000 | 1 | 11 | 12 |
| 2001 | 1 | 14 | 15 |
| 2002 | 3 | 22 | 25 |
| 2003 | 2 | 26 | 28 |
| 2004 | 3 | 22 | 25 |
| 2005 | 1 | 42 | 43 |
| 2006 | 3 | 42 | 45 |
| 2007 | 5 | 48 | 53 |
| 2008 | 12 | 45 | 57 |
| 2009 | 6 | 54 | 60 |
| 2010 | 11 | 67 | 78 |
| 2011 | 12 | 92 | 104 |
| 2012 | 9 | 84 | 93 |
| 2013 | 20 | 92 | 112 |
| 2014 | 19 | 113 | 132 |
| 2015 | 16 | 123 | 139 |
| 2016 | 26 | 119 | 145 |
| 2017 | 17 | 130 | 147 |
| 2018 | 24 | 130 | 154 |
| 2019 | 14 | 139 | 153 |
| 2020 | 20 | 135 | 155 |
| 2021 | 16 | 129 | 145 |
| 2022 | 4 | 103 | 107 |
| 2023 | 5 | 92 | 97 |
| 2024 | 39 | 67 | 106 |
| 2025 | 11 | 99 | 110 |
| 2026 | 13 | 81 | 94 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Longitudinal Repeated Protein Measurements in a Multiethnic Cohort Identify Novel Diabetes Biomarkers That Reveal Unique Disease Pathways. Diabetes. 2026 Nov 01; 75(11):2094-2105.
-
Role of Plasma Proteins in the Association Between Socioeconomic Status and Cardiovascular Disease Events: Results From Trans-Omics for Precision Medicine Cohorts. J Am Heart Assoc. 2026 Nov 03; 15(21):e043751.
-
Associations of Mild or Trace Valvular Abnormalities With Cardiac Remodeling in Older Adults: The ARIC Study. J Am Heart Assoc. 2026 Oct 20; 15(20):e049301.
-
CfDNA methylation profiling in blood following moderate-to-severe traumatic brain injury using brain cell type-enriched signatures: A pilot study. PLoS One. 2026; 21(10):e0358763.
-
Updates in COPD Management: From Inflammatory Pathways to Targeted Therapies. Eur J Clin Invest. 2026 Oct; 56(10):e70256.
-
Comparing diagnostic tools for heart failure with preserved ejection fraction across community and clinical cohorts. Heart. 2026 Sep 24; 112(20):1153-1162.
-
Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention. Methodist Debakey Cardiovasc J. 2026; 22(4):28-39.
-
Landscape of Biomarker Use in Critically Ill Patients: Systematic Evidence Map of Acute Kidney Injury and Implications for Practice. Crit Care Med. 2026 Nov 01; 54(11):2935-2943.
-
Defining Clinically Meaningful Within-Patient Changes in Heart Failure: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Oct; 14(10):103310.
-
Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes: Look AHEAD Ancillary Study. JACC Heart Fail. 2026 Nov; 14(11):103296.